ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 174 filers reported holding ACCELERON PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $44,000 | -17.0% | 1,122 | -13.2% | 0.00% | 0.0% |
| Q2 2019 | $53,000 | -89.6% | 1,292 | -88.2% | 0.00% | -90.9% |
| Q1 2019 | $508,000 | +6.3% | 10,914 | -0.6% | 0.01% | -8.3% |
| Q4 2018 | $478,000 | -56.3% | 10,982 | -42.5% | 0.01% | -45.5% |
| Q3 2018 | $1,094,000 | +15.8% | 19,108 | -1.9% | 0.02% | +10.0% |
| Q2 2018 | $945,000 | +39.4% | 19,482 | +12.4% | 0.02% | +33.3% |
| Q1 2018 | $678,000 | – | 17,340 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |